| Identification | Back Directory | [Name]
SR13668 | [CAS]
637774-61-9 | [Synonyms]
SR13668
LS-190469
CHEMBL245030
BMTPVPNVQOYGAP-UHFFFAOYSA-N
SR13668; SR 13668; CHEMBL245030; LS-190469
Indolo[2,3-b]carbazole-2,10-dicarboxylic acid, 5,7-dihydro-6-methoxy-, 2,10-diethyl ester | [Molecular Formula]
C25H22N2O5 | [MDL Number]
MFCD25976855 | [MOL File]
637774-61-9.mol | [Molecular Weight]
430.45 |
| Hazard Information | Back Directory | [Uses]
SR13668 is a potent indole analog derived from indole-3-carbinol (I3C), known for its natural anticancer properties but limited by poor metabolic characteristics. Developed to enhance I3C's anticancer efficacy, SR13668 effectively inhibits growth factor-stimulated Akt activation. It demonstrates strong oral anticancer activity across different cancer types in preclinical studies, showing promise in clinical development due to its favorable safety profile and potent therapeutic effects[1]. | [References]
[1] Computer-Aided Rational Drug Design: A Novel Agent (SR13668) Designed to Mimic the Unique Anticancer Mechanisms of Dietary Indole-3-Carbinol to Block Akt Signaling |
|
| Company Name: |
NCE Biomedical Co.,Ltd.
|
| Telephone: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList15748/0_EN.htm |
| Company Name: |
SPIRO PHARMA
|
| Telephone: |
|
| Website: |
www.spiropharma.com.cn |
|